Skip to content

Clinical trials

Phase 3 Hemophilia A trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Phase: Phase 3 Clear all

140 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20032
20043
20051
20062
20071
20082
20095
20104
20116
20126
20138
20148
20156
20168
20174
201810
20197
20206
202110
20225
20238
20245
20256
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed87
Active, not recruiting13
Terminated13
Recruiting11
Unknown status7
Not yet recruiting5
Withdrawn4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S17
Baxalta now part of Shire13
Hoffmann-La Roche11
Pfizer9
Octapharma8
Bayer6
CSL Behring6
Wyeth is now a wholly owned subsidiary of Pfizer5
Bio Products Laboratory4
BioMarin Pharmaceutical4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A140
Hemophilia B16
Blood Coagulation Disorders12
Coagulation Protein Disorders10
Hematologic Diseases10
Hemorrhagic Disorders9
Blood Coagulation Disorders, Inherited7
Genetic Diseases, Inborn7
Hemostatic Disorders6
Hemorrhage4

Trials

Showing 51 to 75 of 140. Each trial links to its page on Pharma Observatory.

40 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.